Ji D. Xu
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Prognostic value of the neutrophil-to-lymphocyte ratio in POEMS syndrome.
Journal: Clinical and experimental medicine
Published: January 22, 2026
Perforin Expression and Natural Killer-Cell Proportion as Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 24, 2025
Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.
Journal: Blood and lymphatic cancer : targets and therapy
Published: July 29, 2025
Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.
Journal: Therapeutic advances in hematology
Published: June 27, 2025
Expression and clinical significance of S100A8/9 in adults with secondary phagocytic lymphohistiocytosis.
Journal: Frontiers in molecular biosciences
Published: May 05, 2025
Effect of Plasma Epstein-Barr Virus Nucleic Acid Loads on the Clinical Features and Prognosis in Adult Secondary Hemophagocytic Lymphohistiocytosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 27, 2024
LY6E as a new prognostic biomarker of multiple myeloma-related bone disease.
Journal: Scientific reports
Published: April 17, 2024
Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis.
Journal: Annals of hematology
Published: August 18, 2023
Comparison of different treatment regimens and analysis of prognostic factors in secondary hemophagocytic lymphohistiocytosis in adults: A single-center retrospective study.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: March 21, 2023
Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
Journal: Frontiers in immunology
Published: February 09, 2023
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
Journal: Experimental hematology & oncology
Published: November 16, 2020
Last Updated: 09/26/2026